INS and diabetes mellitus: SCs have the role of delaying the progression of DM and promoting the repair of diabetic complications through immunomodulation, vascularization, and modulation of graft-vs.-host response to recover the insulin sensitivity of peripheral tissues, improve the peri-islet microenvironment, and upgrade islet β-cell regeneration (4–6).